Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models

Abstract

Minocycline at a dose of 400 mg/day is expected to be bactericidal. We propose a clinical trial for validation.